S&P 500 Futures
(0.01%) 5 479.00 points
Dow Jones Futures
(-0.01%) 38 815 points
Nasdaq Futures
(0.04%) 19 929 points
Oil
(0.30%) $80.57
Gas
(0.61%) $2.81
Gold
(0.15%) $2 332.60
Silver
(-0.22%) $29.33
Platinum
(-0.01%) $970.80
USD/EUR
(0.04%) $0.932
USD/NOK
(-0.13%) $10.64
USD/GBP
(0.07%) $0.788
USD/RUB
(-1.87%) $86.80

Realaus laiko atnaujinimai Cytokinetics Inc [CYTK]

Birža: NASDAQ Sektorius: Healthcare Pramonė: Biotechnology
BUY
66.67%
return -0.41%
SELL
33.33%
return 0.64%
Atnaujinta18 birž. 2024 @ 16:30

-0.13% $ 52.71

PIRKIMAS 1139 min ago

@ $53.16

Išleistas: 17 birž. 2024 @ 21:31


Grąža: -0.85%


Ankstesnis signalas: birž. 17 - 20:55


Ankstesnis signalas: Pardavimas


Grąža: -0.83 %

Live Chart Being Loaded With Signals

Commentary (18 birž. 2024 @ 16:30):
Our systems believe the stock currently is overvalued by -0.11% compare to its pairs and should correct downwards.

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases...

Stats
Šios dienos apimtis 4 573
Vidutinė apimtis 1.90M
Rinkos kapitalizacija 6.04B
EPS $-1.330 ( Q1 | 2024-05-10 )
Kita pelno data ( $-1.070 ) 2024-08-01
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -9.76
(Sector) 42.63
(Industry) 24.32
ATR14 $1.550 (2.94%)
AADI 0.00%
ABCL 1.47%
ABCM 0.04%
ABEO -0.44%
ABIO 2.17%
ABOS -0.40%
ABSI 0.29%
ABUS 0.33%
ABVX -0.22%
ACAD 0.54%
ACER -17.95%
ACET 0.00%
ACGN 1.29%
ACHL -2.44%
ACHV 1.63%
ACIU 0.00%
ACLX 0.28%
ACRV 0.73%
ACST 0.62%
ACXP 1.68%
ADAG -5.64%
ADAP 0.33%
ADGI 0.87%
ADIL 1.57%
ADMA 0.29%
ADPT -0.96%
ADTX -1.27%
ADVM -0.55%
ADXN -6.11%
AEON 11.51%
AEZS -5.44%
AFMD -0.59%
AGEN -2.52%
AGIO 0.56%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW 53.45%
AKBA -0.95%
AKRO 0.26%
AKTX -2.70%
AKUS 0.00%
ALBO 0.00%
ALDX 0.96%
ALEC 0.44%
ALGS -0.25%
ALKS 0.60%
ALLK 0.00%
ALLO 0.00%
ALLR -0.77%
ALNA 3.16%
ALNY 0.00%
ALPN 0.00%
ALPX 0.00%
ALRN -0.31%
ALT -0.51%
ALVR 0.60%
ALXN 0.00%
ALXO -1.49%
ALZN 0.00%
AMRN -2.37%
AMTI -3.13%
ANAB -0.94%
ANEB -5.58%
ANGN 0.00%
ANIX -1.14%
ANL 0.61%
ANNX -0.56%
ANPC -3.15%
APGE 0.36%
APGN 8.48%
APGNW 30.65%
APLM 10.18%
APLS 0.92%
APLT 0.21%
APM 1.33%
APOP 0.38%
APRE 2.44%
APTO 0.68%
APTX 3.17%
APVO -0.02%
ARAV -13.39%
ARCT -0.43%
ARDS 20.48%
ARDX 0.48%
ARGX -2.25%
ARNA 0.00%
ARPO -0.90%
ARQT -0.75%
ARTL -4.55%
ARTLW 9.80%
ARVN -0.60%
ARWR 0.00%
ASLN 2.75%
ASMB -0.86%
ASND 0.41%
ATAI -0.75%
ATHA -0.38%
ATHE -1.61%
ATHX -33.50%
ATNF -4.37%
ATOS 2.17%
ATRA -2.75%
ATXI -1.66%
ATXS 0.23%
AUPH -0.90%
AURA 0.68%
AUTL -0.23%
AVBP -0.27%
AVEO 0.00%
AVIR -0.28%
AVRO -2.05%
AVTE -4.82%
AVTX 4.15%
AVXL -0.27%
AXLA 0.00%
AXSM -0.66%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 0.11%
BCAB 1.30%
BCDA -0.30%
BCDAW -33.33%
BCEL -1.32%
BCLI -0.05%
BCRX -0.32%
BCTX -0.68%
BCTXW 0.00%
BCYC 0.00%
BDRX 1.05%
BDTX -0.55%
BEAM -0.12%
BFRA -2.91%
BGNE -0.62%
BIOR 0.03%
BIVI 1.73%
BLCM -6.68%
BLI -5.88%
BLPH -0.79%
BLRX 2.36%
BLTE -0.72%
BLU 0.03%
BLUE -1.38%
BMEA -0.39%
BMRN 0.07%
BNOX 10.76%
BNTC 2.46%
BNTX 0.00%
BOLD 0.49%
BOLT -0.50%
BPMC -0.02%
BPTH 1.26%
BPTS -13.47%
BRNS 2.96%
BRTX -9.91%
BTAI 0.75%
BTTX -7.50%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI -0.36%
CABA 0.00%
CADL -0.83%
CALA 60.00%
CALC -1.62%
CALT -0.64%
CAPR -0.60%
CARA 2.12%
CARM 0.97%
CASI -2.41%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS 1.17%
CCCC -0.97%
CCXI 0.00%
CDAK 0.00%
CDIO -3.01%
CDIOW 0.00%
CDMO -0.40%
CDMOP 0.04%
CDT -6.11%
CDTTW 294.32%
CDTX -0.08%
CDXC -1.01%
CDXS -0.34%
CELC 1.03%
CELU 7.05%
CELUW -9.52%
CERC -1.68%
CERE 0.41%
CERO -3.40%
CEROW -44.78%
CFRX -27.95%
CGEM -1.58%
CGEN -1.02%
CGON 0.00%
CGTX 1.39%
CHMA -6.00%
CHRS -0.61%
CINC 0.00%
CING 4.48%
CINGW -48.24%
CKPT -0.49%
CLBS -16.75%
CLDX 2.89%
CLGN 0.30%
CLLS -6.07%
CLNN 9.74%
CLNNW -41.25%
CLRB 0.00%
CLSD -0.85%
CLSN -0.68%
CLVS 0.00%
CMMB 10.18%
CMND 1.82%
CMPI 0.00%
CMPX 0.00%
CMRA 0.40%
CMRAW 33.33%
CMRX 1.11%
CNCE 0.00%
CNSP -8.62%
CNST 0.00%
CNTA 0.31%
CNTB 3.13%
CNTX -1.03%
COCP 0.42%
COEPW -0.66%
COGT -0.11%
CORT 0.10%
COYA 2.22%
CPRX 0.00%
CRBP -2.67%
CRBU 1.14%
CRDF -0.75%
CRGX 0.00%
CRIS 0.73%
CRNX -0.16%
CRSP 0.40%
CRTX 2.63%
CRVO -1.89%
CRVS 0.00%
CSBR 1.19%
CTCX -8.04%
CTIC 0.06%
CTMX 3.65%
CTNM -2.94%
CTXR -1.01%
CUE -0.75%
CVAC -0.86%
CVKD 1.37%
CWBR -2.55%
CYAD -12.96%
CYCC -2.45%
CYCCP -1.79%
CYCN 6.00%
CYT -2.27%
CYTK -0.13%
CYTO -3.23%
DARE 1.19%
DAWN 0.42%
DBTX -0.81%
DBVT 1.01%
DFFN 10.28%
DICE 0.06%
DMAC -0.42%
DNLI 1.12%
DNTH 0.04%
DOMH 1.99%
DRMA 0.00%
DRMAW 0.00%
DRNA 0.00%
DRTS -1.32%
DRTSW 1.01%
DRUG 0.00%
DSGN 0.00%
DTIL -1.19%
DYAI -5.29%
EARS -1.77%
EDIT 4.34%
EDSA 1.04%
EFTR -3.13%
EFTRW -0.26%
EIGR 0.00%
ELAB -2.87%
ELDN 0.71%
ELEV -0.84%
ELOX -12.50%
ELTX -2.33%
ELVN -0.65%
ELYM -1.57%
ENGN -3.89%
ENGNW -7.06%
ENLV 1.44%
ENOB 1.79%
ENSC 0.88%
ENTA -0.75%
ENTO 0.48%
ENTX 1.45%
ENVB 0.94%
EPIX 0.00%
EPRX -0.19%
EPZM 0.00%
EQ 1.40%
EQRX -2.09%
EQRXW 0.00%
ERAS -0.50%
ERNA 4.79%
ERYP 1.30%
ESLA 1.14%
ESLAW -9.25%
ETNB -0.23%
ETON 1.19%
ETTX 0.00%
EVAX 4.45%
EVGN -2.55%
EVLO 50.00%
EWTX -0.58%
EXAI -0.20%
EXEL -1.06%
EYEG -0.43%
EYEN -0.33%
EYPT -0.11%
FATE -0.28%
FBIO 0.00%
FBIOP 1.09%
FBLG -5.34%
FBRX -7.46%
FDMT -0.67%
FENC 0.74%
FGEN 0.00%
FHTX 9.52%
FIXX 0.77%
FMTX 0.00%
FNCH -6.25%
FOLD 0.30%
FREQ 4.76%
FRLN 0.15%
FRTX -0.54%
FSTX 0.00%
FTRE 0.58%
FULC 0.00%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT 3.20%
GANX -0.76%
GBIO 1.37%
GBT 0.01%
GDTC -7.21%
GERN -0.21%
GHRS 3.42%
GLMD -3.30%
GLPG 0.93%
GLSI -1.83%
GLTO 0.00%
GLUE 0.00%
GLYC 2.57%
GMAB 0.81%
GMDA 0.00%
GMTX 0.00%
GNCA -85.71%
GNFT 0.97%
GNLX 0.00%
GNPX 1.84%
GNTA 0.00%
GOSS 13.65%
GOVX 21.43%
GOVXW -24.72%
GPCR 0.56%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -1.42%
GRTX -4.26%
GTHX 0.75%
GUTS -0.74%
GXGXW 41.67%
GYRE 0.17%
HALO 0.51%
HARP 0.09%
HCWB -9.73%
HEPA -6.36%
HGEN -84.62%
HILS 5.66%
HLVX 0.00%
HOOK 0.94%
HOTH -3.73%
HOWL -0.64%
HRMY 0.00%
HRTX 0.31%
HSTO 62.16%
HUMA -0.73%
HUMAW -5.97%
IBRX 0.00%
ICCC 2.84%
ICPT 0.21%
ICU -0.26%
ICUCW -10.39%
ICVX -0.91%
IDRA -23.04%
IDYA -0.13%
IFRX -3.21%
IGMS 0.14%
IKNA 1.15%
IKT 8.90%
IMAB -1.10%
IMCR -1.12%
IMGN 0.02%
IMGO 0.00%
IMMP -1.47%
IMMX -0.49%
IMNM 0.00%
IMNN -0.90%
IMPL -27.27%
IMRA 15.96%
IMRN -2.78%
IMRX 0.33%
IMTX -0.85%
IMTXW -2.70%
IMUX 1.75%
IMV 0.00%
IMVT -1.14%
INAB 0.00%
INBX -0.35%
INCY -0.06%
INDP -3.03%
INFI -52.38%
INKT -0.39%
INM 1.46%
INMB -0.60%
INO 0.00%
INSM 0.15%
INTS 0.84%
INVA 1.55%
INZY -0.22%
IOBT -6.11%
IONS 0.25%
IOVA -0.82%
IPA 0.00%
IPHA -10.64%
IPSC 0.95%
IRON -0.07%
ISEE 0.38%
ITOS -1.31%
ITRM -2.61%
IVA 2.64%
IVVD 0.00%
JAGX -0.26%
JANX 0.17%
JAZZ 0.06%
JNCE 0.00%
JSPR -0.08%
JSPRW 2.33%
JUNS 0.00%
JUNSW 0%
KA -7.96%
KALV -0.42%
KDNY 0.22%
KMPH -0.34%
KNSA -0.05%
KNTE -0.38%
KOD 0.00%
KPRX 8.51%
KPTI -0.28%
KRBP 4.17%
KRON 0.00%
KROS -2.27%
KRRO -16.54%
KRTX 0.03%
KRYS 0.24%
KTRA 10.34%
KTTA -2.85%
KTTAW 8.62%
KURA 0.19%
KYMR -0.38%
KYTX -0.38%
KZIA 8.44%
KZR -0.45%
LABP 0.57%
LBPH -0.97%
LBPS 0.00%
LBPSW 14.81%
LEGN 0.19%
LENZ -1.30%
LEXX -0.34%
LEXXW -9.42%
LGND -0.46%
LGNDV 0.00%
LGVN -12.50%
LIAN 0.00%
LIFE 2.70%
LIPO -1.23%
LIXT 0.40%
LIXTW 27.74%
LJPC -0.32%
LMNL 0.12%
LOGC -0.72%
LPCN 2.99%
LPTX -1.93%
LQDA -0.23%
LRMR 1.25%
LSTA -4.97%
LTRN -2.24%
LUMO 0.00%
LVTX -1.42%
LXEO -1.05%
LXRX -0.29%
LYEL 0.00%
LYRA -1.26%
MACK 0.00%
MBIO 30.45%
MBRX -4.83%
MCRB -0.58%
MDGL 0.06%
MDNA -13.16%
MDWD 1.00%
MDXG 0.73%
MEIP 1.41%
MESO 2.12%
MGNX 0.00%
MGTA -7.74%
MGTX -1.14%
MGX 2.85%
MIRM 1.36%
MIRO 0.59%
MIST 2.96%
MITO 0.00%
MLEC -4.55%
MLECW 9.20%
MLND -5.36%
MLTX 0.09%
MLYS -0.66%
MNKD 0.42%
MNMD 0.53%
MNOV 0.00%
MNPR 3.39%
MOLN 2.88%
MOR -0.54%
MORF 1.36%
MREO 0.00%
MRKR 2.93%
MRNA -0.75%
MRNS 2.76%
MRSN 0.00%
MRTX -0.17%
MRUS -0.02%
MRVI -0.62%
MTCR -1.29%
MTEM 1.54%
MTP -18.50%
MURA -0.30%
MYMD -0.91%
NAMS -0.39%
NAMSW -7.61%
NAUT 1.17%
NBRV 0.71%
NBSE -1.56%
NBTX -5.64%
NCNA -1.64%
NERV 0.00%
NEXI -1.40%
NGM -1.28%
NGNE -3.23%
NKGN 0.78%
NKGNW 39.76%
NKTR -0.85%
NKTX -1.23%
NLSP 156.24%
NLSPW 8.38%
NMRA 0.53%
NMTR -42.97%
NOVN -24.84%
NRBO 0.45%
NRIX 6.34%
NRSN -4.95%
NRSNW 6.50%
NRXP 0.99%
NRXPW -15.65%
NRXS -6.06%
NTBL 2.92%
NTEC -12.45%
NTHI 0%
NTLA -0.16%
NTRBW -6.25%
NUVL 0.43%
NVAX -0.71%
NVCT 1.18%
NVIV -34.28%
NXTC 0.70%
NYMX -0.05%
OABI -0.47%
OABIW 13.46%
OBIO -0.87%
OBSV 0.00%
OCEA -3.21%
OCGN 2.24%
OCS -1.09%
OCUL -1.45%
OCUP 0.00%
ODT -4.27%
OKYO 0.00%
OLMA -0.76%
OMER 0.87%
OMGA 10.22%
ONCO 21.96%
ONCR -3.08%
ONCS 31.87%
ONCT -0.12%
ONCY -0.99%
ONTX -0.47%
ONVO -2.35%
OPNT 0.00%
OPT 0.80%
ORGS -1.72%
ORIC -0.13%
ORMP 0.00%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK 0.26%
OVID -5.29%
OYST 0.00%
PALI 0.86%
PASG -0.99%
PBLA 9.76%
PBM -0.02%
PBYI -0.63%
PCSA 5.71%
PCVX 0.31%
PDSB 0.00%
PEPG 0.70%
PGEN -1.23%
PHAR 2.17%
PHAS 0.00%
PHAT -0.60%
PHIO 5.42%
PHIOW 36.47%
PHVS -0.53%
PHXM -5.20%
PIRS -5.64%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -0.27%
PLUR 0.00%
PMN 0.00%
PMVP 0.00%
PNT 0.16%
PPBT 2.78%
PRAX 6.05%
PRDS 0.93%
PRLD 0.77%
PROG -3.47%
PROK 1.37%
PRQR -5.29%
PRTA 0.34%
PRTC -0.72%
PRTG 6.52%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV 0.00%
PSTX 1.81%
PTCT 0.06%
PTE -0.82%
PTGX 0.03%
PTIXW 2.50%
PULM 3.72%
PXMD -1.92%
PYPD -0.36%
PYXS 1.09%
QLGN 17.13%
QNCX -1.41%
QNRX 3.04%
QSI 0.75%
QSIAW 0.00%
QTTB 0.00%
QURE -0.85%
RAIN -1.63%
RANI 0.00%
RAPT -0.30%
RARE -0.28%
RCKT 0.19%
REGN 0.11%
RENB 0.00%
REPL -0.13%
RETA 0.02%
REUN -0.89%
REVB 5.66%
REVBU 3.46%
REVBW 25.20%
RGLS 0.42%
RGNX 1.12%
RIGL 2.55%
RLAY 0.28%
RLMD 0.00%
RLYB 0.00%
RNA -1.52%
RNAC -1.07%
RNAZ 0.00%
RNXT 0.75%
ROIV 0.28%
ROIVW 4.56%
RPHM -0.60%
RPRX 0.04%
RPTX 1.58%
RUBY 2.70%
RVLP -32.05%
RVMD -0.16%
RVMDW -23.93%
RVNC -0.71%
RVPH 0.00%
RVPHW 11.54%
RXDX 0.09%
RXRX -0.66%
RYTM 0.46%
RYZB 0.02%
RZLT 0.00%
SABS -2.75%
SABSW -32.14%
SAGE 0.71%
SANA -0.17%
SAVA -0.80%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI -8.63%
SCPH 0.00%
SCPS 0.00%
SEEL -1.16%
SEER -0.58%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO 1.55%
SGMT -0.47%
SGTX -2.56%
SIOX 22.63%
SLDB -0.40%
SLGL -2.22%
SLN -1.55%
SLNO 0.38%
SLRX 2.89%
SLS -3.20%
SMMT 0.76%
SNDX 0.25%
SNGX 0.79%
SNPX -3.97%
SONN -4.75%
SPPI -0.49%
SPRB 0.49%
SPRC -2.02%
SPRO 3.13%
SRNE 20.00%
SRPT 0.18%
SRRA 0.00%
SRRK -0.34%
SRZN -1.70%
STAB 0.00%
STOK -0.26%
STRO 0.63%
STSA 0.00%
STTK 0.40%
SURF -0.93%
SVRA -0.52%
SWTX -1.40%
SYBX -0.63%
SYRS -1.75%
TALS -0.73%
TARA -0.78%
TARS 0.00%
TBPH -0.12%
TCBP 1.78%
TCDA 0.00%
TCON 0.00%
TCRR 0.00%
TCRT -3.13%
TCRX -1.21%
TECH 0.07%
TENX -3.43%
TERN 0.00%
TFFP -2.05%
TGTX 0.84%
THRX 0.12%
TIL -2.06%
TLC 0.00%
TLSA 0.66%
TNGX 0.59%
TNXP 0.89%
TNYA 0.00%
TPST 0.34%
TRDA -3.61%
TRVI -0.18%
TRVN -1.88%
TSHA -8.44%
TSVT -0.49%
TTNP 1.45%
TVTX -0.27%
TYRA -0.39%
UBX 0.72%
UNCY -0.11%
URGN -7.55%
UTHR 0.08%
VACC 11.36%
VALN -2.51%
VAXX -0.11%
VBIV 1.15%
VBLT -8.77%
VCEL 0.50%
VCNX -1.54%
VCYT -0.09%
VERA -0.62%
VERU 0.50%
VERV -1.14%
VIGL -2.75%
VINC 1.05%
VIR -0.87%
VIRI -1.96%
VIRX -6.84%
VKTX -0.25%
VLON -13.04%
VNDA 0.63%
VOR 0.85%
VRCA 0.00%
VRDN -0.74%
VRNA 0.50%
VRPX -11.90%
VRTX -0.06%
VSTM 0.29%
VTGN 1.46%
VTVT -0.10%
VTYX -0.36%
VXRT 5.20%
VYGR 0.85%
VYNE 2.16%
VYNT 7.78%
WINT 5.59%
WVE -0.67%
XBIO 6.75%
XBIT -0.66%
XCUR -0.65%
XENE 0.30%
XERS 0.00%
XFOR -0.54%
XLO 0.00%
XLRN 0.00%
XNCR -0.41%
XOMA 0.00%
XOMAO -0.56%
XOMAP -0.14%
XRTX 2.97%
YMAB 0.26%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -1.26%
ZNTL -24.91%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-06-17 Parshall B Lynne Buy 5 000 Common Stock
2024-06-17 Parshall B Lynne Sell 5 000 Common Stock
2024-06-17 Parshall B Lynne Sell 5 000 Non-Qualified Stock Option (Right to Buy)
2024-06-17 Blum Robert I Sell 11 551 Common Stock
2024-06-17 Blum Robert I Sell 10 949 Common Stock
INSIDER POWER
5.56
Last 99 transactions
Buy: 573 733 | Sell: 523 480
Koreliacija (AI algo v.1.1b): Overvalued: -0.11% $52.84 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: -0.51 (weak negative)
Trumpas: 0.74 (moderate)
Signal:(51) Neutral

Cytokinetics Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
OZEM1
KLXE0.905
AGRI0.903
BNAI0.901
BRLT0.9
FWRD0.897
SVC0.893
PZZA0.892
BCTX0.89
CHUY0.888
10 Labiausiai neigiamai susiję koreliacijos
RFAIU-0.918
GOGL-0.9
GODN-0.893
IBKR-0.892
AFAR-0.89
ACGL-0.886
WING-0.884
BYNO-0.882
SFM-0.877
APXI-0.877

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Cytokinetics Inc Koreliacija - Valiuta/Žaliavos

The country flag 0.43
( neutral )
The country flag 0.49
( neutral )
The country flag -0.31
( neutral )
The country flag -0.21
( neutral )
The country flag 0.17
( neutral )
The country flag -0.67
( moderate negative )

Cytokinetics Inc Finansinės ataskaitos

Annual 2023
Pajamos: $7.53M
Bruto pelnas: $-4.36M (-57.93 %)
EPS: $-5.45
FY 2023
Pajamos: $7.53M
Bruto pelnas: $-4.36M (-57.93 %)
EPS: $-5.45
FY 2022
Pajamos: $94.59M
Bruto pelnas: $-146.23M (-154.59 %)
EPS: $-4.48
FY 2021
Pajamos: $70.43M
Bruto pelnas: $0.00 (0.00 %)
EPS: $-2.68

Financial Reports:

No articles found.

Cytokinetics Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Cytokinetics Inc

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure; and reldesemtiv, a skeletal muscle troponin activator, which is in Phase III clinical trial to treat amyotrophic lateral sclerosis and spinal muscular atrophy. The company also develops CK-136, a novel cardiac troponin activator that is in Phase I clinical trial; aficamten, a novel cardiac myosin inhibitor, which is in Phase III clinical trial for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy; and CK-3772271, a small molecule cardiac myosin inhibitor that is in Phase I clinical trial. Cytokinetics, Incorporated has a strategic alliance with Astellas Pharma Inc. The company was incorporated in 1997 and is headquartered in South San Francisco, California.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.

Total Execution Time: 2.3868951797485 seconds
Number of API calls: 3
Number of DB calls: 9